Phasing out the pre-transplant cytotoxicity crossmatch: Are we missing something?

INTRODUCTION: The anti-human globulin-enhanced complement-dependent cytotoxicity crossmatch (AHG-CDCXM) assay has been used to assess the presence of donor-specific antibodies (DSA) in recipient’s serum before kidney transplantation. The flow cytometric crossmatch (FCXM) assay was first introduced a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abud, Jamile, Pupo, Bruna Brasil Dal, da Silva, Cynthia, Keitel, Elizete, Garcia, Valter Duro, Manfro, Roberto Ceratti, Neumann, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428636/
https://www.ncbi.nlm.nih.gov/pubmed/33899906
http://dx.doi.org/10.1590/2175-8239-JBN-2019-0222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428636/
https://www.ncbi.nlm.nih.gov/pubmed/33899906
http://dx.doi.org/10.1590/2175-8239-JBN-2019-0222

Ejemplares similares